Suppr超能文献

微小 RNA-613:人类癌症中的一种新型肿瘤抑制因子。

MicroRNA-613: A novel tumor suppressor in human cancers.

机构信息

The First Clinical Medicine College, Nanjing Medical University, Nanjing, 211166, China; Cytoskeleton Research Group, Nanjing Medical University, Nanjing, 211166, China.

Cytoskeleton Research Group, Nanjing Medical University, Nanjing, 211166, China; School of Basic Medical Sciences, Nanjing Medical University, Nanjing, 211166, China.

出版信息

Biomed Pharmacother. 2020 Mar;123:109799. doi: 10.1016/j.biopha.2019.109799. Epub 2019 Dec 23.

Abstract

MicroRNAs (miRNAs) are short-chain non-coding RNAs that act as critical roles in malignant tumorigenesis via regulating the expression of tumor-associated genes through post-transcriptional level based on specific binding to their target genes. MicroRNA-613 (miR-613) is a new-found miRNA and emerging evidences show that miR-613 participates in multiple physiological and pathological processes. Recent studies have exhibited that miR-613 is abnormally expressed in a variety of cancers and act as important roles in the progression of cancers. To be specific, miR-613 is generally identified as a tumor suppressor in multiple cancers. In this review, we systematically summarize the roles of miR-613 and highlight the potential correlation between miR-613 expression and clinical features in human cancers.

摘要

MicroRNAs (miRNAs) 是短链非编码 RNA,通过与靶基因的特异性结合,在转录后水平上调节肿瘤相关基因的表达,从而在恶性肿瘤发生中发挥关键作用。MicroRNA-613 (miR-613) 是一种新发现的 miRNA,越来越多的证据表明 miR-613 参与多种生理和病理过程。最近的研究表明,miR-613 在多种癌症中异常表达,并在癌症的进展中发挥重要作用。具体来说,miR-613 在多种癌症中通常被鉴定为肿瘤抑制因子。在这篇综述中,我们系统地总结了 miR-613 的作用,并强调了 miR-613 表达与人类癌症临床特征之间的潜在相关性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验